CJC-1295 No DAC (Mod GRF 1-29)

Growth Hormone SecretagogueResearch Use Only

Also known as: Mod GRF 1-29, Modified GRF 1-29, CJC-1295 without DAC, Sermorelin analog

CJC-1295 without DAC, often called Modified GRF 1-29, is a short-acting GHRH analog comprising the first 29 amino acids of GHRH with stabilizing substitutions. It is commonly referenced in research literature studying pulsatile growth-hormone release. This entry is educational and research-use-only and is not medical advice.

Typical range (research)

Commonly referenced in literature around 100 mcg per administration, sometimes up to a few times daily (research reference only)

Half-life

~30 minutes (short-acting)

Route

Subcutaneous (research)

Common use

Studied as a short-acting GHRH analog intended to mimic natural growth-hormone pulses

Common vial sizes

5 mg

Storage

Lyophilized powder stored refrigerated or frozen away from light; reconstituted solution refrigerated (2–8 °C) and used within a few weeks

Stacking notes

Frequently paired with a GHRP such as Ipamorelin or GHRP-2 for synergistic growth-hormone release in research protocols

Reported side effects

Injection-site reactionFlushing reported anecdotallyTransient tingling reported anecdotally

Regulatory note: Not an approved therapeutic; sold for research purposes only

Calculate a dose →

Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Not for human or veterinary use. Consult a licensed physician.